Chicago Mandal, Ananya
Study finds no statistical link between use of semaglutide and other GLP-1 drugs and risk of degenerative eye disease in adults with type 2 diabetes A study following more than 200,000 adult, first-time users of GLP-1 drugs found the medications did not increase or decrease the risk of developing a blinding eye condition An estimated 27% of U.S
Source: Piaopiao, L et al JAMA Network Open October 31, 2025
Epididymal Function Research: Investigation of sperm maturation processes occurring during epididymal transit
Most people report noticing changes after roughly 4 to 8 weeks of consistent daily use, not days
Related research: For distinct compound, component, or formulation evidence and safety context, read Semaglutide Peptide: Benefits, Uses, Side Effects, Dosage, and Research and Cagrilintide Peptide: Benefits, Uses, Side Effects, Dosage, and Research